Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Incidence of AIDS dementia in a two-year follow-up of AIDS and ARC patients on an initial phase II AZT placebo-controlled study: San Diego cohort.

Day JJ, Grant I, Atkinson JH, Brysk LT, McCutchan JA, Hesselink JR, Heaton RK, Weinrich JD, Spector SA, Richman DD.

J Neuropsychiatry Clin Neurosci. 1992 Winter;4(1):15-20.

PMID:
1627957
2.

The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.

Cooper DA, Pehrson PO, Pedersen C, Moroni M, Oksenhendler E, Rozenbaum W, Clumeck N, Faber V, Stille W, Hirschel B, et al.

AIDS. 1993 Feb;7(2):197-207.

PMID:
8096703
3.

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al.

Ann Intern Med. 1990 May 15;112(10):727-37.

PMID:
1970466
4.
5.

Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex.

Schmitt FA, Bigley JW, McKinnis R, Logue PE, Evans RW, Drucker JL.

N Engl J Med. 1988 Dec 15;319(24):1573-8.

PMID:
3059187
6.

Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex.

Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard PM, Perronne C, Salmon D, De Truchis P, Leport C, et al.

Lancet. 1988 Dec 3;2(8623):1297-302.

PMID:
2904016
8.

Presentation and course of AIDS dementia complex: 10 years of follow-up in Amsterdam, The Netherlands.

Portegies P, Enting RH, de Gans J, Algra PR, Derix MM, Lange JM, Goudsmit J.

AIDS. 1993 May;7(5):669-75.

PMID:
8318174
9.

The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.

Pedersen C, Cooper DA, Brun-Vézinet F, Doherty R, Skinhøj P, Pérol Y, Lüthy R, Leibowitch J, Habermehl KO, Varnier OE, et al.

AIDS. 1992 Aug;6(8):821-5.

PMID:
1418778
10.

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group.

Sidtis JJ, Gatsonis C, Price RW, Singer EJ, Collier AC, Richman DD, Hirsch MS, Schaerf FW, Fischl MA, Kieburtz K, et al.

Ann Neurol. 1993 Apr;33(4):343-9.

PMID:
8489204
11.

Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.

Fischl MA, Richman DD, Causey DM, Grieco MH, Bryson Y, Mildvan D, Laskin OL, Groopman JE, Volberding PA, Schooley RT, et al.

JAMA. 1989 Nov 3;262(17):2405-10.

PMID:
2677429
12.

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.

Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, et al.

N Engl J Med. 1987 Jul 23;317(4):185-91.

PMID:
3299089
13.

Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial.

Goldstein G, Conant MA, Beall G, Grossman HA, Galpin JE, Blick G, Calabrese LH, Hirsch RL, Fisher A, Stampone P, et al.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):279-88.

PMID:
7859140
14.

Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)

Mulder JW, Cooper DA, Mathiesen L, Sandström E, Clumeck N, Gatell JM, French M, Donovan B, Gray F, Yeo JM, et al.

AIDS. 1994 Mar;8(3):313-21. Erratum in: AIDS 1994 Jun;8(6):following 859.

PMID:
7913326
18.

Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.

Moore RD, Keruly J, Richman DD, Creagh-Kirk T, Chaisson RE.

AIDS. 1992 Jul;6(7):671-7.

PMID:
1503686
19.

Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group.

Chiesi A, Vella S, Dally LG, Pedersen C, Danner S, Johnson AM, Schwander S, Goebel FD, Glauser M, Antunes F, et al.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Jan 1;11(1):39-44.

PMID:
8528731
20.

Quality of life in a placebo-controlled trial of zidovudine in patients with AIDS and AIDS-related complex.

Wu AW, Mathews WC, Brysk LT, Atkinson JH, Grant I, Abramson I, Kennedy CJ, McCutchan JA, Spector SA, Richman DD.

J Acquir Immune Defic Syndr. 1990;3(7):683-90.

PMID:
2191113

Supplemental Content

Support Center